145 related articles for article (PubMed ID: 26362969)
1. Ex vivo relaxations of pulmonary arteries induced by prostacyclin mimetics are highly dependent of the precontractile agents.
Benyahia C; Ozen G; Orie N; Ledwozyw A; Louedec L; Li F; Senbel AM; Silverstein A; Danel C; Longrois D; Clapp LH; Norel X; Topal G
Prostaglandins Other Lipid Mediat; 2015 Sep; 121(Pt A):46-52. PubMed ID: 26362969
[TBL] [Abstract][Full Text] [Related]
2. A comparative study of PGI2 mimetics used clinically on the vasorelaxation of human pulmonary arteries and veins, role of the DP-receptor.
Benyahia C; Boukais K; Gomez I; Silverstein A; Clapp L; Fabre A; Danel C; Leséche G; Longrois D; Norel X
Prostaglandins Other Lipid Mediat; 2013 Dec; 107():48-55. PubMed ID: 23850788
[TBL] [Abstract][Full Text] [Related]
3. Differential actions of the prostacyclin analogues treprostinil and iloprost and the selexipag metabolite, MRE-269 (ACT-333679) in rat small pulmonary arteries and veins.
Orie NN; Ledwozyw A; Williams DJ; Whittle BJ; Clapp LH
Prostaglandins Other Lipid Mediat; 2013 Oct; 106():1-7. PubMed ID: 23872196
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of Selexipag [corrected] and prostacyclin analogs in rat pulmonary artery.
Morrison K; Studer R; Ernst R; Haag F; Kauser K; Clozel M
J Pharmacol Exp Ther; 2012 Dec; 343(3):547-55. PubMed ID: 22918043
[TBL] [Abstract][Full Text] [Related]
5. A comparison of vasodilation mode among selexipag (NS-304; [2-{4-[(5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy}-N-(methylsulfonyl)acetamide]), its active metabolite MRE-269 and various prostacyclin receptor agonists in rat, porcine and human pulmonary arteries.
Fuchikami C; Murakami K; Tajima K; Homan J; Kosugi K; Kuramoto K; Oka M; Kuwano K
Eur J Pharmacol; 2017 Jan; 795():75-83. PubMed ID: 27919660
[TBL] [Abstract][Full Text] [Related]
6. Thromboxane receptor stimulation suppresses guanylate cyclase-mediated relaxation of radial arteries.
Arshad M; Vijay V; Floyd BC; Marks B; Sarabu MR; Wolin MS; Gupte SA
Ann Thorac Surg; 2006 Jun; 81(6):2147-54. PubMed ID: 16731144
[TBL] [Abstract][Full Text] [Related]
7. Role of prostanoid IP and EP receptors in mediating vasorelaxant responses to PGI2 analogues in rat tail artery: Evidence for Gi/o modulation via EP3 receptors.
Orie NN; Clapp LH
Eur J Pharmacol; 2011 Mar; 654(3):258-65. PubMed ID: 21185823
[TBL] [Abstract][Full Text] [Related]
8. Binding and activity of the prostacyclin receptor (IP) agonists, treprostinil and iloprost, at human prostanoid receptors: treprostinil is a potent DP1 and EP2 agonist.
Whittle BJ; Silverstein AM; Mottola DM; Clapp LH
Biochem Pharmacol; 2012 Jul; 84(1):68-75. PubMed ID: 22480736
[TBL] [Abstract][Full Text] [Related]
9. Relaxant actions of nonprostanoid prostacyclin mimetics on human pulmonary artery.
Jones RL; Qian YM; Wise H; Wong HN; Lam WL; Chan HW; Yim AP; Ho JK
J Cardiovasc Pharmacol; 1997 Apr; 29(4):525-35. PubMed ID: 9156364
[TBL] [Abstract][Full Text] [Related]
10. Involvement of protein kinase C in reduced relaxant responses to the NO/cyclic GMP pathway in piglet pulmonary arteries contracted by the thromboxane A2-mimetic U46619.
Pérez-Vizcaíno F; Villamor E; Duarte J; Tamargo J
Br J Pharmacol; 1997 Aug; 121(7):1323-33. PubMed ID: 9257910
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of cyclic AMP-mediated vasorelaxation by phenylephrine in pulmonary arteries of the rat.
Priest RM; Hucks D; Ward JP
Br J Pharmacol; 1999 May; 127(1):291-9. PubMed ID: 10369485
[TBL] [Abstract][Full Text] [Related]
12. Interaction between PGI
Ozen G; Benyahia C; Amgoud Y; Patel J; Abdelazeem H; Bouhadoun A; Yung S; Li F; Mahieddine Y; Silverstein AM; Castier Y; Cazes A; Longrois D; Clapp LH; Norel X
Prostaglandins Other Lipid Mediat; 2020 Feb; 146():106388. PubMed ID: 31672620
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor-β/δ, the acute signaling factor in prostacyclin-induced pulmonary vasodilation.
Li Y; Connolly M; Nagaraj C; Tang B; Bálint Z; Popper H; Smolle-Juettner FM; Lindenmann J; Kwapiszewska G; Aaronson PI; Wohlkoenig C; Leithner K; Olschewski H; Olschewski A
Am J Respir Cell Mol Biol; 2012 Mar; 46(3):372-9. PubMed ID: 22021335
[TBL] [Abstract][Full Text] [Related]
14. A long-acting and highly selective prostacyclin receptor agonist prodrug, 2-{4-[(5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy}-N-(methylsulfonyl)acetamide (NS-304), ameliorates rat pulmonary hypertension with unique relaxant responses of its active form, {4-[(5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy}acetic acid (MRE-269), on rat pulmonary artery.
Kuwano K; Hashino A; Noda K; Kosugi K; Kuwabara K
J Pharmacol Exp Ther; 2008 Sep; 326(3):691-9. PubMed ID: 18552131
[TBL] [Abstract][Full Text] [Related]
15. Bronchodilation induced by PGE
Ozen G; Benyahia C; Mani S; Boukais K; Silverstein AM; Bayles R; Nelsen AC; Castier Y; Danel C; Mal H; Clapp LH; Longrois D; Norel X
Br J Pharmacol; 2020 Jan; 177(1):161-174. PubMed ID: 31476020
[TBL] [Abstract][Full Text] [Related]
16. Comparison of relaxation responses to multiple vasodilators in TxA(2)-analog and endothelin-1-precontracted pulmonary arteries.
Piamsomboon C; Tanaka KA; Szlam F; Makita T; Huraux C; Levy JH
Acta Anaesthesiol Scand; 2007 Jul; 51(6):714-21. PubMed ID: 17488313
[TBL] [Abstract][Full Text] [Related]
17. Relaxant effect of the prostacyclin analogue iloprost on isolated human radial artery: An approach for the reversal of graft spasm.
Engin E; Alp Yildirim Fİ; Kalelі Durman D; Ömeroğlu SN; Göksedef D; Teskіn Ö; Balkanay OO; İpek G; Uydeş Doğan BS
Prostaglandins Other Lipid Mediat; 2017 Nov; 133():35-41. PubMed ID: 29107024
[TBL] [Abstract][Full Text] [Related]
18. Endothelium-dependent relaxation and effects of prostacyclin, endothelin and platelet-activating factor in human hand veins and arteries.
Arner M; Högestätt ED
Acta Physiol Scand; 1991 Jun; 142(2):165-72. PubMed ID: 1715111
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary vasoconstrictor effects of prostacyclin in rats: potential role of thromboxane receptors.
Zhao YJ; Wang J; Tod ML; Rubin LJ; Yuan XJ
J Appl Physiol (1985); 1996 Dec; 81(6):2595-603. PubMed ID: 9018511
[TBL] [Abstract][Full Text] [Related]
20. Selexipag: a selective prostacyclin receptor agonist that does not affect rat gastric function.
Morrison K; Ernst R; Hess P; Studer R; Clozel M
J Pharmacol Exp Ther; 2010 Oct; 335(1):249-55. PubMed ID: 20660124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
